In this study, we explored the use of serum NfL and candidate genetic variables as potential prognostic biomarkers in a large and well-studied cohort of recently diagnosed PD patients with prolonged follow-up and high clinical diagnostic certainty. The gene discussed is NEFL; the disease is Parkinson disease.